We provide you with 20 years of free, institutional-grade data for ATRI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ATRI. Explore the full financial landscape of ATRI stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Battat David A | Grant, award...etc | 1,276 | 2024-08-21 | ||
| Battat David A | Derivatives Exercise | 310 | 2024-07-11 | ||
| BATTAT EMILE A | Derivatives Exercise | 310 | 2024-07-01 | ||
| Battat David A | Derivatives Exercise | 310 | 2024-07-01 | ||
| Ferguson Cindy | Sale | -45 | $440.8 | $19,836 | 2024-03-11 |
| Ferguson Cindy | Derivatives Exercise | 163 | 2024-03-11 | ||
| Athey Preston G | Open Market Purchase | 300 | $319.68 | 2023-12-01 | |
| Battat David A | Open Market Purchase | 300 | $300 | 2023-11-16 | |
| Bankes Jeannette | Grant, award...etc | 186 | $444.03 | 2023-09-21 | |
| Athey Preston G | Open Market Purchase | 200 | $523.35 | 2023-08-18 | |
| Athey Preston G | Grant, award...etc | 200 | $523.35 | 2023-08-15 | |
| BATTAT EMILE A | Derivatives Exercise | 310 | 2023-07-03 | ||
| Battat David A | Derivatives Exercise | 310 | 2023-07-03 | ||
| STUPP JOHN P JR | Grant, award...etc | 224 | 2023-05-25 | ||
| Athey Preston G | Grant, award...etc | 112 | 2023-05-25 | ||
| Spaulding Ronald Nicholas | Grant, award...etc | 224 | 2023-05-25 | ||
| MORGAN HUGH J JR | Grant, award...etc | 224 | 2023-05-25 | ||
| BATTAT EMILE A | Derivatives Exercise | 620 | 2023-03-21 | ||
| Battat David A | Derivatives Exercise | 620 | 2023-03-21 | ||
| STRICKLAND JEFFERY | Derivatives Exercise | 776 | 2023-03-07 | ||
| STRICKLAND JEFFERY | Sale | -33 | $628.21 | $20,731 | 2023-03-07 |
| STRICKLAND JEFFERY | Derivatives Exercise | 136 | 2023-03-07 | ||
| STRICKLAND JEFFERY | Sale | -1,000 | $675 | $675,000 | 2022-10-27 |
| STRICKLAND JEFFERY | Sale | -82 | $627.8 | $51,480 | 2022-08-26 |
| STRICKLAND JEFFERY | Derivatives Exercise | 338 | 2022-08-26 | ||
| Battat David A | Sale | -3,591 | $646.66 | $2,322,156 | 2022-06-28 |
| Battat David A | Derivatives Exercise | 2,000 | 2022-06-28 | ||
| BATTAT EMILE A | Sale | -3,186 | $646.66 | $2,060,259 | 2022-06-28 |
| BATTAT EMILE A | Derivatives Exercise | 4,000 | 2022-06-28 | ||
| STUPP JOHN P JR | Grant, award...etc | 172 | 2022-05-26 | ||
| Sainz Maria | Grant, award...etc | 172 | 2022-05-26 | ||
| Athey Preston G | Grant, award...etc | 100 | 2022-05-26 | ||
| Spaulding Ronald Nicholas | Grant, award...etc | 172 | 2022-05-25 | ||
| MORGAN HUGH J JR | Grant, award...etc | 172 | 2022-05-25 | ||
| STRICKLAND JEFFERY | Sale | -127 | $622.16 | $79,014 | 2022-05-25 |
| STRICKLAND JEFFERY | Derivatives Exercise | 524 | 2022-05-25 | ||
| Sainz Maria | Grant, award...etc | 18 | $704.9 | 2022-01-04 | |
| BATTAT EMILE A | Sale | -3 | $713 | $2,139 | 2021-12-22 |
| BATTAT EMILE A | Sale | -261 | $683 | $178,263 | 2021-12-16 |
| Sainz Maria | Grant, award...etc | 94 | $703.63 | 2021-09-01 | |
| MORGAN HUGH J JR | Grant, award...etc | 154 | 2021-05-25 | ||
| Spaulding Ronald Nicholas | Grant, award...etc | 154 | 2021-05-25 | ||
| STUPP JOHN P JR | Grant, award...etc | 154 | 2021-05-25 | ||
| Athey Preston G | Grant, award...etc | 154 | 2021-05-25 | ||
| Battat David A | Sale | -5,024 | $685 | $3,441,440 | 2021-03-16 |
| Battat David A | Derivatives Exercise | 0 | 2021-03-16 | ||
| BATTAT EMILE A | Sale | -4,607 | $685 | $3,155,795 | 2021-03-16 |
| BATTAT EMILE A | Derivatives Exercise | 0 | 2021-03-16 | ||
| Spaulding Ronald Nicholas | Grant, award...etc | 24 | 2020-07-02 | ||
| STUPP JOHN P JR | Grant, award...etc | 24 | 2020-07-02 | ||
| MORGAN HUGH J JR | Grant, award...etc | 24 | 2020-07-02 | ||
| Athey Preston G | Grant, award...etc | 24 | 2020-07-02 | ||
| STUPP JOHN P JR | Grant, award...etc | 93 | 2020-05-22 |
The information provided in this report about ATRI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Atrion Corporation(NASDAQ:ATRI) 
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amo...
Website: http://www.atrioncorp.com
Founded: 1944
Full Time Employees: 616
Sector: Healthcare
Industry: Medical Instruments & Supplies